A few things come to mind....two years ago we were at $5. Between now and then the FDA gave us a bad report card with new guidelines, then we opened up a new lab on 57th st, and now just the other day officially secured our IP.
From here we will start to move into partnerships, personally i think Biotime would be a good fit since they have the cells and the ECM for next gen cosmetic surgery. BTX will also soon receive a CE mark in the EU, so it might be good timing with SVFC's international patent also coming.
Above all, extracting autologous stem cells from fat will be the first stem cell boom and pharma knows this. All major sports teams are currently lining up and will likely be the first clients.
As far as i know their competition is CYTX, might be some other machines out there, but the good reviews from our product should insure a piece of the adipose pie.